EX-10.1
Published on May 15, 2026
Exhibit 10.1
FIRST AMENDMENT TO LOAN AGREEMENT
This FIRST AMENDMENT TO LOAN AGREEMENT (this “Amendment”), dated as of May 15, 2026, is entered into by and among TUHURA BIOSCIENCES, INC., a Nevada corporation (“Borrower”), and PARKVIEW HOLDINGS ONE LLC, a Florida limited liability company (“Lender”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Loan Agreement referenced below.
RECITALS:
WHEREAS, Borrower and Lender are party to that certain Loan Agreement, dated as of April 21, 2026 (together with all exhibits and schedules thereto and any further amendments and modifications thereof from time to time made in accordance with the terms thereof being hereinafter referred to as the “Loan Agreement”); and
WHEREAS, Borrower and Lender desire to amend the Loan Agreement to incorporate certain terms that were agreed to between Borrower and Lender as of the Closing Date, but which, as the result of a scrivener’s error, were not reflected in the Loan Agreement.
NOW, THEREFORE, in consideration of the premises, and for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, it is hereby agreed by the parties hereto as follows:
“Section 7.05 Limitation on Dispositions. Dispose of any of its property, whether now owned or hereafter acquired, or issue or sell any Equity Interests (other than Equity Interests of Borrower) to any Person, except:”
2
[signature pages follow]
3
IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and delivered by their authorized officers as of the day and year first above written.
BORROWER:
|
TUHURA BIOSCIENCES, INC.
By: /s/ James Bianco Name: James Bianco, M.D. Title: Chief Executive Officer
|
|
LENDER:
PARKVIEW HOLDINGS ONE LLC
By: /s/ Vijay Patel Name: Vijay Patel Title: Manager
|
CONSENT AND REAFFIRMATION
May [●], 2026
Each of the undersigned hereby (i) acknowledges receipt of a copy of the foregoing First Amendment to Loan Agreement (the “Amendment”); (ii) consents to Borrower’s execution and delivery of the Amendment; (iii) agrees to be bound by the Amendment; (iv) acknowledges and agrees that (x) after giving effect to the Amendment, neither the Amendment or any other Loan Documented effected pursuant to the Amendment nor the execution, delivery, performance or effectiveness of the Amendment or any other Loan Document shall impair the validity, effectiveness or priority of the Liens granted pursuant to the Security Documents (as in effect immediately prior to the date hereof, the “Existing Security Documents”) and such Liens shall continue unimpaired with the same priority to secure repayment of all Obligations, whether heretofore or hereafter incurred; and (y) neither the modification of the Laon Agreement effected pursuant to the Amendment nor the execution, delivery, performance or effectiveness of the Amendment requires that any new filings be made or other action taken to perfect or maintain the perfection of such Liens; and (v) the priority position of Lender with respect to such Liens, the Collateral in which a security interest has been granted pursuant to the Existing Security Documents, and the ability of Lender to realize upon such Liens pursuant to the terms of the Security Documents have not been adversely affected by modification of the Loan Agreement effected pursuant to the Amendment or by the execution, delivery, performance or effectiveness of the Amendment. Each of the undersigned hereby affirms that, except as set forth in the Amendment, nothing contained therein shall modify in any respect whatsoever any Loan Document to which the undersigned is a party and reaffirms that each such Loan Document is and shall continue to remain in full force and effect. Although each of the undersigned has been informed of the matters set forth herein and has consented to and acknowledged the same, each of the undersigned understands that the Lender has no obligation to inform the undersigned of such matters in the future or to seek the undersigned’s consent or acknowledgement or agreement to future amendments, waivers or consents, and nothing herein shall create such a duty.
[signature page follows]
IN WITNESS WHEREOF, each of the undersigned has executed this Consent and Reaffirmation on and as of the date of the Amendment.
|
ADGERO BIOPHARMACEUTICALS HOLDINGS, INC., a Delaware corporation
By: Name: James Bianco, M.D. Title: Chief Executive Officer
|
|
ADGERO BIOPHARMACEUTICALS, INC., a Delaware corporation
By: Name: James Bianco, M.D. Title: Chief Executive Officer
|
|
TUHURA BIOSCIENCES, INC., a Delaware corporation
By: Name: James Bianco, M.D. Title: Chief Executive Officer
|
|
KINETA, LLC, a Delaware limited liability company
By: Name: James Bianco, M.D. Title: President
|
[Signature Page to Consent and Reaffirmation]